skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Nuclear Medicine Program progress report for quarter ending September 30, 1989

Technical Report ·
DOI:https://doi.org/10.2172/5358657· OSTI ID:5358657

In this report, an evaluation of the effects of albumin and albumin plus sodium palmitate in the phosphate buffer perfusate on the relative of unmetabolized fatty acid and the unknown metabolite(s) from isolated rat hearts administered 15-(p-(I-125)iodophenyl)-3-(R, S)-methylpentadecanoic acid (BMIPP) is described. Earlier studies had demonstrated the presence of a major unidentified polar radioactive component in the outflow of hearts injected with BMIPP and perfused with the traditional Krebs-Henseleit (KH) buffer, which does not contain albumin. The current studies were performed with KH buffer containing either albumin (BSA) or albumin and palmitate (BSA/PAL) to assess the relative loss of the metabolite and unmetabolized BMIPP from the perfused hearts. The results demonstrated that in the presence of albumin both the unidentified material and BMIPP are present in the outflow (i.e., 5 min perfusate buffer, % BMIPP: KH, 3%; KH + BSA, 10%; KH + BSA/PAL, 41%). These results demonstrate that BMIPP is a major radioactive component in the outflow of isolated hearts using a perfusate containing BSA and palmitate and, more importantly, suggest for the first time that the slow myocardial wash-out observed in humans after administration of (I-123)BMIPP probably represents loss of both unmetabolized BMIPP and the unidentified metabolite. Coronary sinus sampling studies with dogs are now in progress to relate the relative contribution of these two components to the release of radioactivity from the heart. Also in this report, our population experience for several radioisotopes being used by the ORNL Nuclear Medicine Program is summarized.

Research Organization:
Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
Sponsoring Organization:
DOE/ER
DOE Contract Number:
AC05-84OR21400
OSTI ID:
5358657
Report Number(s):
ORNL/TM-11377; ON: DE90004434
Country of Publication:
United States
Language:
English